Search Results - "Mela Osorio, María J"

PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients by Ferrari, Luciana C, Rivas, María M, Navickas, Alicia B, Dick, Hernán, Mela Osorio, María J, Agamennoni, Lucía, Rey, Irene H, Carnelutto, Natalia E, Cazap, Nicolás, Castro, María B, Aranguren, Pedro Negri, Fischman, Laura A, Yupanki, Marco Lincango, Milone, Jorge H, Fernández, Isolda I, Moirano, María M, Belli, Carolina B

“…Intensified pediatric chemotherapy regimens to treat adolescents and young adults (AYA) patients with Philadelphia negative acute lymphoblastic leukemia (ALL)…”
Get full text

PLZF-RAR α , NPM1-RAR α , and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review by Sobas, Marta, Talarn-Forcadell, Maria Carme, Martínez-Cuadrón, David, Escoda, Lourdes, García-Pérez, María J, Mariz, Jose, Mela-Osorio, María J, Fernández, Isolda, Alonso-Domínguez, Juan M, Cornago-Navascués, Javier, Rodríguez-Macias, Gabriela, Amutio, María E, Rodríguez-Medina, Carlos, Esteve, Jordi, Sokół, Agnieszka, Murciano-Carrillo, Thais, Calasanz, María J, Barrios, Manuel, Barragán, Eva, Sanz, Miguel A, Montesinos, Pau

“…It has been suggested that 1-2% of acute promyelocytic leukemia (APL) patients present variant rearrangements of retinoic acid receptor alpha (RARα) fusion…”
Get full text

Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status by Mela Osorio, María J., Ferrari, Luciana, Goette, Nora P., Gutierrez, Marina I., Glembotsky, Ana C., Maldonado, Ana C., Lev, Paola R., Alvarez, Clarisa, Korin, Laura, Marta, Rosana F., Molinas, Felisa C., Heller, Paula G.

“…Background Anagrelide represents a treatment option for essential thrombocythemia, although its place in therapy remains controversial. Aim To assess the…”
Get full text

Chronic myelogenous leukemia: monitoring and predictors of a favorable response to treatment with imatinib by Mela Osorio, María J, Giere, Isabel A, Fernández, Isolda, Pavlovsky, Miguel A, Intile, Dante, Pavlovsky, Carolina

“…The expected five-year survival of chronic-phase chronic myeloid leukemia patients treated with tyrosine kinase inhibitors is over 90%. Little data is…”
Get full text

Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study by Pavlovsky, Miguel, Cubero, Daniel, Agreda-Vásquez, Gladys Patricia, Enrico, Alicia, Mela-Osorio, Maria J, San Sebastián, Jorge Armenta, Fogliatto, Laura, Ovilla, Roberto, Avendano, Oscar, Machnicki, Gerardo, Barreyro, Paula, Trufelli, Damila, Villanova, Pamella

“…Real-world evidence on non-Hodgkin lymphoma (NHL) management in Latin America is currently lacking. The objective of this study was to describe treatment…”
Get full text

Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report by Burgos, Sebastian, Montalban-Bravo, Guillermo, Fuente, Lucia, Jabbour, Elias J., Kanagal-Shamanna, Rashmi, Soltysiak, Kelly A., Garcia-Manero, Guillermo, Mela-Osorio, Maria J.

“…The gene deletion (5)(q22q35) is reported in 10-20% of myelodysplastic syndrome (MDS) cases and is associated with response to lenalidomide and favorable…”
Get full text

Ph-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA) Treated with Pediatric Argentine BFM-like Protocol: Real-Word Data on Prognostic Factors and Treatment by Ferrari, Luciana C, Rivas, María M, Fernandez, Isolda I, Sackmann, Federico, Mela Osorio, María J, Navickas, Alicia B, Agamennoni, Lucía, Rey, Irene, Aguerre, Laura, Dick, Hernan, Carnelutto, Natalia, Gómez, Mariela, Castro, María B, Basquiera, Ana L, Moya, Eliana, Negri Aranguren, Florencia, Negri Aranguren, Pedro, Fishman, Laura, Costa, Lucila, Cazap, Nicolás, Fornillo, Florencia, Paganini, María I, Rapan, María L, Freue, Julian, Clavijo, Manuela, Ramírez, Roxana, Milone, Jorge, Pavlovsky, Miguel A, Belli, Carolina B, Moirano, María M, Argentine Society of Hematology, On behalf of Acute Leukemia Committee

“…Background: ALL in adults is considered a heterogeneous disease with poor prognosis. However, adolescents and young adults (AYA) display intermediate…”
Get full text

Long‐term follow‐up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK 2 / CALR / MPL mutational status by Mela Osorio, María J., Ferrari, Luciana, Goette, Nora P., Gutierrez, Marina I., Glembotsky, Ana C., Maldonado, Ana C., Lev, Paola R., Alvarez, Clarisa, Korin, Laura, Marta, Rosana F., Molinas, Felisa C., Heller, Paula G.

“…Abstract Background Anagrelide represents a treatment option for essential thrombocythemia, although its place in therapy remains controversial. Aim To assess…”
Get full text

Ruxolitinib In Myelofibrosis (MF) Patients Through Compassionate Use Program (CUP). Argentinian Experience by Alzate, Mauricio A, Mela Osorio, María J, Barreyro, Paula, Enrico, Alicia Inés, García de Labanca, Ana, Negri, Pedro, Varela, Ana Inés, Vitriu, Adriana, Bär, Daniel, Benzadón, Ricardo, Burgos, Rubén, Celebrín, Lucía, Ceresetto, Jose Manuel, Corzo, Ariel, Fernández, Isolda, Flores, María Gabriela, Galeazzi, Ana Victoria, Lanari Zubiaur, Emilio A, Molinas, Felisa C., Orlando, Sergio M, Pavlovsky, Miguel A, Remaggi, Guillermina, Riveros, Dardo Alberto, Rudoy, Silvia, Taborda, Gustavo, Sánchez Avalos, Julio César, Sackmann, Federico, Bengió, Raquel M

“…MF is a myeloproliferative neoplasm characterized by bone marrow fibrosis, splenomegaly, cytopenias and constitutional symptoms. Since the identification of…”
Get full text

Economic Impact Analysis of Treatment-Free Remission in Chronic Myeloid Leukemia Patients with Sustained Deep Molecular Response in the AST-2018 Trial by Tannuri, Ricardo Khalil Khalil, Moiraghi, Beatriz, Pavlovsky, Miguel Arturo, Varela, Ana Ines, Bianchini, Michele, Giere, Isabel, Fernandez, Isolda I., Bendek, Georgina, Mariano, Romina, Freitas, Josefina, Ventriglia, Veronica, Custidiano, Maria Del Rosario, Garcia de Labanca, Ana, Sanchez Avalos, Julio Cesar, Mela Osorio, Maria J., Vasconcelos Cordoba, Bianca, Sanchez, Maria Belen, Juni, Mariana, Bianco, Marcos, Pavlovsky, Carolina

Get full text

Ex-Vivo Testing Using Patient Micro Avatars (PMAs) Predicts Clinical Response in Acute Leukemias by Garcia, Alejandra, Buffa, Lía, Ridano, Magalí, Scaglia, Paula, Nicola, Maribel, Carbajosa, Sofía, Garro, Cintia, Arroyo, Daniela, Conrrero, Agustina, Fiorenza, Juan Pablo, Alfonso, Valentina, Bernaschini, María Laura, Andino, Diego, Cavallo, Natalia, Ferreira, Gimena, García, Virginia, Molineris, Federico, Zeballos, Maximiliano, Palmer, Silvina, Fernandez, Isolda I, Mela Osorio, Maria J, Pavlovsky, Carolina, García, Juan José, Alonso, Martín, Rossi, Blanca de los Milagros, Jarchum, Gustavo, Rodriguez, Daiana, Arruda, Andrea, Minden, Mark D., Cazap, Nicolás, Solimano, Jorge, Zaki, Tarek Ali, Gatti, Gerardo, Llorens, Candelaria, Soria, Gastón

Get full text

Impact on Quality of Life (QoL) of Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Under Ibrutinib Treatment: Preliminary Data from a Real World Prospective Project (pilot study) by Mela Osorio, Maria J., Pavlovsky, Carolina, Juni, Mariana, Fernandez, Isolda I., Ferrari, Luciana C., Ciliberti, Esteban, Pavlovsky, Miguel A.

“…Introduction Ibrutinib (Ibr), is a first-in-class, orally administered covalent inhibitor of Bruton Tirosine Kinase (BTK). In Argentina, IMBRUVICA™ has…”
Get full text

Novel EZH2 Mutation in a Patient with Second Primary B-Cell Acute Lymphoblastic Leukemia after del5q Myelodysplastic Syndrome by Canales, Sebastian Burgos, Fuente, Maria L., Bravo, Guillermo Montalban, Garcia-Manero, Guillermo, Mela Osorio, Maria J.

Get full text

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study by Ovilla, Roberto, Crisp, Renee Leonor, Baez-Islas, Pamela E, Arbelbide, Jorge A, Grille, Sofia, Díaz, Lilián, Idrobo, Henry, Enrico, Alicia, Mela Osorio, Maria J, Fernandez, Isolda I., Ferrari, Luciana C, Zapata, Nidia, Ceballos-Lopez, Adrian A, Mena, Veronica, Romero, Ana L, Serrano, Juan Carlos, Vidal-Senmache, Gabriela, Barroso Duarte, Fernando, Pintos, Edit N, Rosenhain, Mariana, Kornblihtt, Laura, Tejeira, Natalia, Gusmao, Breno, Buenaño, Maria Elena Del Rocio, Di Stefano, Marcos, Boada, Matilde, Gimenez Conca, Alberto, Perusini, Maria, Dick, Hernan, Cranco, Santiago, Fuente, Maria Lucia, Navickas, Alicia Beatriz, Moirano, Maria M, Oliveira, Natalia, Gonzalez, Jacqueline, Bandín, Mariana, Villaverde, Noelia, Suero, Alejandro, Lasso, Juan Felipe, Carrara, Nora, Cota, Xochitl, Lazzarino, Carolina, Rapan, Maria Leticia, Iastrebner, Marcelo, (GLAM), Latin-American MDS Group, Argentinian Society of Hematology, MDS and Acute Leukemia Sub-Commission Group

“…▪ INTRODUCTION Secondary Acute Myeloid Leukemia (s-AML) evolves from a previous hematopoietic clonal disease such as Myelodysplastic Syndromes (MDS/AML),…”
Get full text